Regulatory PathRegulatory requirements compared

Active substance

Lactulose

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
DUPHALAC ORAL SOLUTION667 g/lOral solution · Oral use1 BottleSAR 24.40NCE · OTCABBOTT BIOLOGICALSValid
EZILAX 10G-15ML SYRUP0.67 g/mlSyrup · Oral use1 BottleSAR 21.95Generic · OTCTabuk Pharmaceutical Manufacturing CompanyValid
KULAX 65MG-100ML SYRUP0.65 mg/mlSyrup · Oral use1 BottleSAR 15.25Generic · OTCKUWAIT SAUDI PHARMACEUTICAL INDUSTRIESValid
KULAX 65MG-100ML SYRUP0.65 mg/mlSyrup · Oral use1 BottleSAR 10.15Generic · OTCKUWAIT SAUDI PHARMACEUTICAL INDUSTRIESValid
LACTULOSE syrup0.65 g/mlSyrup · Oral use1 BottleSAR 17.00Generic · OTCEIPICOValid
LAXILOSE SYRUP67 %Syrup · Oral use1 BottleSAR 18.45Generic · OTCSAUDI PHARMACEUTICAL INDUSTRIESValid
LAXOLAC SYRUP0.65 g/mlSyrup · Oral use1 BottleSAR 7.00Generic · OTCMEDICAL UNION PHARMACEUTICALS COValid
LAXOLAC SYRUP0.65 g/mlSyrup · Oral use1 BottleSAR 15.25Generic · OTCMEDICAL UNION PHARMACEUTICALS COValid
SOFLAX SOLUTION0.67 g/mlSolution · Oral use1 BottleSAR 9.95Generic · OTCGulf Pharmaceutical Industries (Julphar)Valid
DEFOLAX 65GM-100ML SYRUP0.65 g/mlSyrup · Oral use1 BottleSAR 11.20Generic · OTCDEEF PHARMACEUTICAL INDUSTRIESWithdrawn by MAH · Not Marketed
EZILAX 10GM POWDER SACHET10 gPowder for oral solution · Oral use20 SachetSAR 16.80NCE · OTCTabuk Pharmaceutical Manufacturing CompanyWithdrawn by MAH · Not Marketed
RAMLAC 67GM-100ML SYRUP0.67 g/mlSyrup · Oral use1 BottleSAR 13.75Generic · OTCRam Pharmaceutical IndustriesWithdrawn by MAH · Not Marketed
RIALAC LIQUID0.67 g/mlOral solution · Oral use1 BottleSAR 11.10Generic · OTCRIYADH PHARMAWithdrawn by MAH · Not Marketed
RIALAC LIQUID0.67 g/mlOral solution · Oral use1 BottleSAR 15.55Generic · OTCRIYADH PHARMAWithdrawn by MAH · Not Marketed
SEDALAC SYRUP 3.35G-5ML0.65 g/mlOral solution · Oral use1 BottleSAR 6.30Generic · OTCSEDICOWithdrawn by regulatory authority · Not Marketed
Indications — CHI Daman Drug Formulary

ACUTE LIVER FAILURE - HEPATIC ENCEPHALOPATHY/HYPERAMMONEMIA; ANAL FISSURE; CONSTIPATION; HEMORRHOIDS; IRRITABLE BOWEL SYNDROME; LIVER CIRRHOSIS

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
LACTULOSE10GM/15MLsolution · oralPHARM ASSOCPrescription30 Jul 1996
GENERLAC10GM/15MLsolution · oral, rectalCHARTWELL RXPrescription31 Oct 1996
LACTULOSE10GM/15MLsolution · oralAUROBINDO PHARMA LTDPrescription14 Nov 1996
LACTULOSE10GM/PACKET; 20GM/PACKETfor solution · oralAPOTEXPrescription10 Dec 1997
LACTULOSE10GM/15MLsolution · oralLANNETT CO INCPrescription26 Jul 2001
LACTULOSE10GM/15MLsolution · oralPHARMOBEDIENTPrescription21 Feb 2002
LACTULOSE10GM/15MLsolution · oral, rectalBAJAJPrescription28 Jul 2003
LACTULOSE10GM/15MLsolution · oral, rectalFRESENIUS KABIPrescription25 Jan 2012
LACTULOSE10GM/15MLsolution · oralFRESENIUS KABIPrescription25 Jan 2012
LACTULOSE10GM/15MLsolution · oral, rectalAPOZEAL PHARMSPrescription27 Mar 2015
LACTULOSE10GM/15MLsolution · oralAPOZEAL PHARMSPrescription11 Jun 2018
LACTULOSE10GM/15MLsolution · oralCHARTWELL RXPrescription23 Nov 2018
LACTULOSE10GM/15MLsolution · oralTAROPrescription13 Dec 2024
LACTULOSE10GM/PACKET; 20GM/PACKETfor solution · oralPAI HOLDINGSPrescription14 Mar 2025
CEPHULAC10GM/15ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**solution · oral, rectalSANOFI AVENTIS USDiscontinued25 Mar 1976
CHRONULAC10GM/15ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**solution · oralSANOFI AVENTIS USDiscontinued20 Jun 1979
CONSTILAC10GM/15MLsolution · oralALRADiscontinued26 Jul 1988
CHOLAC10GM/15MLsolution · oral, rectalALRADiscontinued26 Jul 1988
CONSTULOSE10GM/15MLsolution · oralACTAVIS MID ATLANTICDiscontinued15 Aug 1988
ENULOSE10GM/15MLsolution · oral, rectalACTAVIS MID ATLANTICDiscontinued15 Aug 1988
LACTULOSE10GM/15MLsolution · oral, rectalROXANEDiscontinued29 May 1992
LACTULOSE10GM/15MLsolution · oralHIKMA PHARMSDiscontinued29 May 1992
LACTULOSE10GM/15MLsolution · oralVISTAPHARM LLCDiscontinued30 Sep 1992
EVALOSE10GM/15MLsolution · oralTEVA PHARMSDiscontinued28 May 1993
HEPTALAC10GM/15MLsolution · oral, rectalTEVA PHARMSDiscontinued28 May 1993

13 more — full table

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
JAMP-LACTULOSE02295881667 MG / MLSOLUTION · ORALJAMP PHARMA CORPORATION
LACTULOSE02412268667 MG / MLSOLUTION · ORALSANIS HEALTH INC
PMS-LACTULOSE-PHARMA02469391667 MG / MLSOLUTION · ORALPHARMASCIENCE INC
RATIO-LACTULOSE00854409667 MG / MLSOLUTION · ORALTEVA CANADA LIMITED
TEVA-LACTULOSE02331551667 MG / MLSOLUTION · ORALTEVA CANADA LIMITED

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACCONSTULOSE 10 GM/15 ML SOLN$0.01947per ML23 Sep 2026
US NADACCONSTULOSE 10 GM/15 ML SOLN$0.01939per ML23 Sep 2026
US NADACENULOSE 10 GM/15 ML SOLUTION$0.01304per ML23 Sep 2026
US NADACGENERLAC 10 GM/15 ML SOLUTION$0.01304per ML23 Sep 2026
US NADACLACTULOSE 10 GM PACKET$8.22014per EA23 Sep 2026
US NADACLACTULOSE 10 GM/15 ML SOLUTION$0.01947per ML23 Sep 2026
US NADACLACTULOSE 10 GM/15 ML SOLUTION$0.02237per ML23 Sep 2026
US NADACLACTULOSE 10 GM/15 ML SOLUTION$0.01939per ML23 Sep 2026
US NADACLACTULOSE 10 GM/15 ML SOLUTION$0.01304per ML23 Sep 2026
US NADACLACTULOSE 10 GM/15 ML SOLUTION$0.0125per ML23 Sep 2026
US NADACLACTULOSE 20 GM PACKET$8.51402per EA23 Sep 2026
US NADACLACTULOSE 20 GM/30 ML SOLUTION CUP$0.0512per ML18 Feb 2026
NHS Drug TariffLactulose 10g/15ml oral solution 15ml sachets sugar free£3.5210 sachet1 Oct 2026
NHS Drug TariffLactulose 3.1-3.7g/5ml oral solution£3.63500 ml1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

WHO WHO Model List of Essential Medicines (2025)

  • 2.3. Medicines for other common symptoms in palliative care · core
    Palliative care
    Oral > Liquid: 3.3 to 3.4 g per 5 mL oral liquid (EMLc)

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.